VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VOLY: The Monetary Value of a Life-Year at the End of Patients’ Lives
Authors
Keywords
-
Journal
Applied Health Economics and Health Policy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-04
DOI
10.1007/s40258-023-00829-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
- (2022) Sándor Kovács et al. Applied Health Economics and Health Policy
- A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain
- (2021) Mac Ardy Junio Gloria et al. VALUE IN HEALTH
- Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
- (2021) Luka Vončina et al. Applied Health Economics and Health Policy
- Willingness to pay for QALY: perspectives and contexts in Japan
- (2019) Ataru Igarashi et al. JOURNAL OF MEDICAL ECONOMICS
- NICE, the NHS, and Cancer Drugs
- (2018) Andrew Dillon et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Valuing health at the end of life: A review of stated preference studies in the social sciences literature
- (2018) Koonal K. Shah et al. SOCIAL SCIENCE & MEDICINE
- Re-Thinking ‘The Different Perspectives That can be Used When Eliciting Preferences in Health’
- (2017) Aki Tsuchiya et al. HEALTH ECONOMICS
- Cancer drugs: high price, uncertain value
- (2017) Deborah Cohen BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Cancer drugs: high price, uncertain value
- (2017) Deborah Cohen BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
- (2016) Beth Woods et al. VALUE IN HEALTH
- How you ask is what you get: Framing effects in willingness-to-pay for a QALY
- (2016) Marlies Ahlert et al. SOCIAL SCIENCE & MEDICINE
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
- (2015) N. I. Cherny et al. ANNALS OF ONCOLOGY
- Preferences for end-of-life care among community-dwelling older adults and patients with advanced cancer: A discrete choice experiment
- (2015) Eric A. Finkelstein et al. HEALTH POLICY
- A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?
- (2015) Khachapon Nimdet et al. PLoS One
- The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature
- (2014) Linda Ryen et al. HEALTH ECONOMICS
- Valuing QALYs at the end of life
- (2014) Jose-Luis Pinto-Prades et al. SOCIAL SCIENCE & MEDICINE
- ASSESSING WHETHER THERE IS A CANCER PREMIUM FOR THE VALUE OF A STATISTICAL LIFE
- (2013) W. Kip Viscusi et al. HEALTH ECONOMICS
- Comparing WTP Values of Different Types of QALY Gain Elicited from the General Public
- (2013) Mark Pennington et al. HEALTH ECONOMICS
- Is a QALY still a QALY at the end of life?
- (2012) Jeff Round JOURNAL OF HEALTH ECONOMICS
- GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation
- (2011) Ana Bobinac et al. JOURNAL OF HEALTH ECONOMICS
- Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness
- (2011) Kevin Haninger et al. RISK ANALYSIS
- PCN143 WILLINGNESS TO PAY FOR A LIFE-YEAR GAINED FROM THE PERSPECTIVE OF THE GENERAL POPULATION
- (2011) M Obradovic et al. VALUE IN HEALTH
- Economic valuation of air pollution mortality: A 9-country contingent valuation survey of value of a life year (VOLY)
- (2010) B. Desaigues et al. ECOLOGICAL INDICATORS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search